Kiley Juergens Wealth Management’s Aptiv APTV Stock Holding History

Kiley Juergens Wealth Management’s Portfolio APTV Stock Details APTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-428	Closed	–	–	78
2018 Q3	$0	Hold	428	–	–	﹤0.01%	637
2018 Q2	$0	Buy	+428	New	+$39.9K	﹤0.01%	576
2018 Q1	–	Sell	-450	Closed	-$38K	–	116
2017 Q4	$38K	Buy	+450	New	+$42.8K	0.03%	234

Other funds holding APTV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kiley Juergens Wealth Management's APTV Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of Aptiv (APTV) in Q4 2018, closing a stake of 428 shares.

Kiley Juergens Wealth Management first reported a position in APTV in Q4 2017 and held it in 3 quarters. The position peaked at $38K in Q4 2017. 603 funds tracked by Wall St. Rank hold APTV as of Q4 2018.

Kiley Juergens Wealth Management reported no remaining Aptiv position as of Q4 2018 after selling out during the quarter.
Kiley Juergens Wealth Management sold 428 Aptiv shares in Q4 2018.
Kiley Juergens Wealth Management first reported a position in Aptiv in Q4 2017 and held it in 3 quarters.
Kiley Juergens Wealth Management's Aptiv position peaked at $38K in Q4 2017.
603 funds tracked by Wall St. Rank held Aptiv as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.